COPD at a Street Level
A Study of the Incidence and Treatment of Impaired Lung Function Among Socially Vulnerable Individuals at a Street Level
1 other identifier
interventional
511
1 country
1
Brief Summary
The trial investigates and describes the prevalence of COPD among socially vulnerable individuals who come in contact with a mobile clinic and investigates the effect of opportunistic screening for COPD in these vulnerable persons. The study population is individuals who come in contact with a mobile clinic, that visits home shelters, open drugs scenes etc. in the Capital Region of Denmark during the inclusion period, and monitor them for up to 1 year in order to investigate variables that are significant in terms of the patients' treatment, hospitalizations, and mortality in relation to COPD. Our hypothesis is that there will be a higher incidence of COPD among socially vulnerable individuals who come in contact with the mobile clinic than in the general population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2022
CompletedFirst Posted
Study publicly available on registry
December 21, 2022
CompletedStudy Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2029
April 9, 2024
April 1, 2024
4 years
December 13, 2022
April 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Prevalence of COPD
1\. Prevalence of obstructive lung function reduction among socially vulnerable
Baseline
Undiagnosed COPD
2\. Prevalence of previously undetected COPD
Baseline
Adherence to first appointment
3\. Numbers of socially vulnerable individuals diagnosed with obstructive lung function that are subsequently examined at a pulmonary medicine outpatient clinic/GP
Baseline
Subscription at first appointment
4\. Number of socially vulnerable individuals who after COPD diagnosis are subscribed medical treatment
Baseline
Secondary Outcomes (5)
Smoking status
Baseline
COPD and smoking cessation
Baseline
smoking cessation invitation
Baseline
Adherence to treatment
Baseline
Health service barriers
Baseline
Study Arms (1)
Socially vulnerable individuals in contact with a mobile clinic
OTHERAfter obtaining informed consent, a project nurse in the mobile clinic reviews the online-questionnaire with the participant and performs a lung function examination requiring the individual to blow into a plastic tube. If the participant is identified as having obstructive reduction of lung function, they are offered a referral and patient support to a local pulmonary medicine department or GP for further investigation - regardless of whether or not they have a diagnosed or undiagnosed lung disease. In addition, participants are questioned about their motivation for smoking cessation and are informed of the options for this (in hospital and/or referral to the municipality).
Interventions
The method of examination, Spirometry, is noninvasive (i.e. not an intervention that involves penetration into the body by means of incisions or injections.). It is a routine examination and there are no risks, adverse reactions, or discomforts associated with the examination.
Eligibility Criteria
You may qualify if:
- years or older
- Able to speak and understand Danish or English to such an extent that informed consent can be obtained
You may not qualify if:
- \- Not having a Danish civil registration number, since foreign patients do not have free access to examinations and medical treatment, and cannot be followed up in the national patient registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hvidovre University Hospitallead
- Brugernes Akademicollaborator
Study Sites (1)
Brugernes Akademi
Copenhagen, 1660, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jannet van der Veen
Brugernes Akademi
- PRINCIPAL INVESTIGATOR
Charlotte S Ulrik
Amager and Hvidovre Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, consultant
Study Record Dates
First Submitted
December 13, 2022
First Posted
December 21, 2022
Study Start
March 15, 2023
Primary Completion (Estimated)
March 15, 2027
Study Completion (Estimated)
January 31, 2029
Last Updated
April 9, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share